Compare ImmunityBio Inc. Common Stock (IBRX) vs Vivmark Residential Common Shares of Beneficial Interest (VMRK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ImmunityBio Inc. Common Stock vs Vivmark Residential Common Shares of Beneficial Interest — how do they compare? ImmunityBio Inc. Common Stock trades at $10 (market cap $10.33B), while Vivmark Residential Common Shares of Beneficial Interest trades at $60.01 (market cap $45.88B). The key difference: Vivmark Residential Common Shares of Beneficial Interest is far larger — about 4.4× ImmunityBio Inc. Common Stock's market cap, and Vivmark Residential Common Shares of Beneficial Interest pays a 4.74% dividend while ImmunityBio Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold ImmunityBio Inc. Common Stock for 0 Days and Vivmark Residential Common Shares of Beneficial Interest for 0 Days on average.
| IBRX | VMRK | |
|---|---|---|
Market Cap | $10.33B | $45.88B |
Volume | 11,745,198 | 4,028,975 |
Sector | Health | Real Estate |
52-Week High | $11.55 | $70.15 |
52-Week Low | $1.98 | $57.98 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $10.79B | $54.98B |
Dividend Yield | — | 4.74% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About ImmunityBio Inc. Common Stock
ImmunityBio develops immune-based therapies for cancer and infectious diseases. Its programs are designed to activate and strengthen the body’s immune response.
Read more on IBRX →About Vivmark Residential Common Shares of Beneficial Interest
Vivmark Residential is a residential real estate investment trust that owns and operates apartment communities in U.S. markets. Its portfolio includes apartment homes and development projects.
Read more on VMRK →
